OXFORD ASSET MANAGEMENT LLP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$68,000
-92.5%
51,359
-58.0%
0.00%
-93.1%
Q3 2015$908,000
+57.6%
122,264
+469.2%
0.03%
+123.1%
Q3 2013$576,00021,4800.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders